Co-Authors
This is a "connection" page, showing publications co-authored by Aron Hall and Fiona Havers.
Connection Strength
1.125
-
Changes in Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Over Time in 10 Sites in the United States, March-August, 2020. Clin Infect Dis. 2021 11 16; 73(10):1831-1839.
Score: 0.245
-
Comparison of Estimated Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Through Commercial Laboratory Residual Sera Testing and a Community Survey. Clin Infect Dis. 2021 11 02; 73(9):e3120-e3123.
Score: 0.244
-
Hospitalization of Adolescents Aged 12-17 Years with Laboratory-Confirmed COVID-19 - COVID-NET, 14 States, March 1, 2020-April 24, 2021. MMWR Morb Mortal Wkly Rep. 2021 Jun 11; 70(23):851-857.
Score: 0.238
-
Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020. JAMA Intern Med. 2020 Jul 21.
Score: 0.223
-
Changes in Influenza and Other Respiratory Virus Activity During the COVID-19 Pandemic - United States, 2020-2021. MMWR Morb Mortal Wkly Rep. 2021 Jul 23; 70(29):1013-1019.
Score: 0.060
-
Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020. JAMA Intern Med. 2021 04 01; 181(4):450-460.
Score: 0.059
-
Risk for In-Hospital Complications Associated with COVID-19 and Influenza - Veterans Health Administration, United States, October 1, 2018-May 31, 2020. MMWR Morb Mortal Wkly Rep. 2020 Oct 23; 69(42):1528-1534.
Score: 0.057